Abstract
Myocardial blood flow (MBF) quantification by Rubidium-82 (Rb82) positron emission tomography (PET) has shown utility for cardiac allograft vasculopathy surveillance and cardiovascular risk stratification post heart transplantation (HT). The objective of this study was to determine the prognostic value of serial Rubidium-82 PET examinations performed early after HT.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
